Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer

Spiliotis J, Halkia E


The most common cause of primary ovarian malignancy is epithelial carcinoma, accounting for 95% of malignant ovarian neoplasia. The lifetime risk of epithelial ovarian cancer (EOC) is 1/70 females, representing the leading cause of gynecologic malignancy death. Due to its indolent clinical course, EOC tends to be diagnosed at an advanced stage, often resulting in unfavorable outcomes, since the stage at diagnosis is the most significant prognostic factor. So far the standard of care for ovarian cancer has been surgery followed by systemic chemotherapy. However, treatment with cytoreductive surgery, as described by Sugarbaker, and hyperthermic intraperitoneal chemotherapy (HIPEC) is another approach, showing promising results.

Full Text:




  • There are currently no refbacks.

Case Studies in Surgery  ISSN 2377-7311(Print)  ISSN 2377-732X(Online)

Copyright © Sciedu Press

To make sure that you can receive messages from us, please add the '' and ‘’ domains to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', please check your 'spam' or 'junk' folder.